Literature DB >> 27311615

(-)-Rhazinilam and the diphenylpyridazinone NSC 613241: Two compounds inducing the formation of morphologically similar tubulin spirals but binding apparently to two distinct sites on tubulin.

Ruoli Bai1, Ernest Hamel2.   

Abstract

The most potent microtubule assembly inhibitor of newer diphenylpyridazinone derivatives examined was NSC 613241. Because NSC 613241 and (-)-rhazinilam also induce the formation of similar 2-filament spirals, these aberrant reactions were compared. Spiral formation with both compounds was enhanced by GTP and inhibited by GDP and by 15 other inhibitors of microtubule assembly. Similarly, microtubule assembly induced by paclitaxel or laulimalide is enhanced by GTP and inhibited by GDP and assembly inhibitors, but neither [(3)H]NSC 613241 nor [(3)H](-)-rhazinilam bound to microtubules or inhibited the binding of [(3)H]paclitaxel or [(3)H]peloruside A to microtubules. Differences in the pitch of aberrant polymers were found: NSC 613241-induced and (-)-rhazinilam-induced spirals had average repeats of 85 and 79-80 nm, respectively. We found no binding of [(3)H]NSC 613241 or [(3)H](-)-rhazinilam to αβ-tubulin dimer, but both compounds were incorporated into the polymers they induced in substoichiometric reactions, with as little as 0.1-0.2 mol compound/mol of tubulin, and no cross-inhibition by NSC 613241 or (-)-rhazinilam into spirals occurred. Under reaction conditions where neither compound induced spiral formation, both compounds together synergistically induced substantial spiral formation. We conclude that (-)-rhazinilam and NSC 613241 bind to different sites on tubulin that differ from binding sites for other antitubulin agents. Published by Elsevier Inc.

Entities:  

Keywords:  (−)-Rhazinilam; 4-morpholineethanesulfonate; DPP; Diphenylpyridazinone derivatives; Glutaraldehyde-fixed microtubules; HPLC; Inhibition of tubulin assembly; MAPs; Mes; NSC 613241; Tubulin polymer of aberrant morphology; diphenylpyridazinone; gMTs; glutaraldehyde-fixed microtubules; high-performance liquid chromatography; microtubule-associated proteins

Mesh:

Substances:

Year:  2016        PMID: 27311615      PMCID: PMC4955782          DOI: 10.1016/j.abb.2016.06.008

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  37 in total

1.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

Authors:  Raimond B G Ravelli; Benoît Gigant; Patrick A Curmi; Isabelle Jourdain; Sylvie Lachkar; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

2.  Interactions of taxol, microtubule-associated proteins, and guanine nucleotides in tubulin polymerization.

Authors:  E Hamel; A A del Campo; M C Lowe; C M Lin
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

3.  LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.

Authors:  M de Arruda; C A Cocchiaro; C M Nelson; C M Grinnell; B Janssen; A Haupt; T Barlozzari
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

4.  Complete amino acid sequence of beta-tubulin from porcine brain.

Authors:  E Krauhs; M Little; T Kempf; R Hofer-Warbinek; W Ade; H Ponstingl
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

5.  Cabazitaxel for the treatment of castration-resistant prostate cancer.

Authors:  Neeraj Agarwal; Guru Sonpavde; Oliver Sartor
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

Review 6.  The place for eribulin in the treatment of metastatic breast cancer.

Authors:  William J Gradishar
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

7.  Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges.

Authors:  W R Gamble; N A Durso; R W Fuller; C K Westergaard; T R Johnson; D L Sackett; E Hamel; J H Cardellina; M R Boyd
Journal:  Bioorg Med Chem       Date:  1999-08       Impact factor: 3.641

8.  Rhazinilam mimics the cellular effects of taxol by different mechanisms of action.

Authors:  B David; T Sévenet; M Morgat; G Guénard; A Moisand; Y Tollon; O Thoison; M Wright
Journal:  Cell Motil Cytoskeleton       Date:  1994

9.  Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.

Authors:  Eric J Gapud; Ruoli Bai; Arun K Ghosh; Ernest Hamel
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436

Review 10.  Physical and spectroscopic methods for the evaluation of the interactions of antimitotic agents with tubulin.

Authors:  S N Timasheff; J M Andreu; G C Na
Journal:  Pharmacol Ther       Date:  1991-11       Impact factor: 12.310

View more
  3 in total

Review 1.  Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

Authors:  April L Risinger; Lin Du
Journal:  Nat Prod Rep       Date:  2019-11-25       Impact factor: 13.423

Review 2.  Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.

Authors:  Li Liu; Devin O'Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

3.  Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment.

Authors:  Yihang Guo; Honghong Wang; Jeni L Gerberich; Samuel O Odutola; Amanda K Charlton-Sevcik; Maoping Li; Rajendra P Tanpure; Justin K Tidmore; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason; Li Liu
Journal:  Cancers (Basel)       Date:  2021-09-24       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.